The next board meeting for Ovid Therapeutics Inc is on 11 Mar 2026 for the purpose of Ovid Therapeutics Inc Fourth Quarter Earnings Results for 2025See details
Ovid Therapeutics Inc has a share price target of US$ 4, revenue growth forecast of 1057.9%, and profit growth estimate of -51.5% for FY25, based on top 11 analyst calls.